Inborn errors of metabolism
a clinical overview
Palavras-chave:
Erros inatos do metabolismo, Doença metabólica hereditária, DiagnósticoResumo
CONTEXTO: Os erros inatos do metabolismo (EIM) causam as doenças metabólicas hereditárias (DMH) e classicamente resultam da falta de atividade de uma ou mais enzimas específicas ou defeitos no transporte de proteínas. OBJETIVOS: Revisão clínica sobre Erros Inatos do Metabolismo (EIM) voltada para o médico na sua prática diária, com tabelas e figuras que sumariam as diversas doenças que fazem parte deste assunto. Uma pequena revisão das bases bioquímicas suficiente para compreensão da fisiopatologia dos EIM. FONTES DOS DADOS: Pesquisa bibliográfica utilizando livros de textos sobre os EIM e suas bases bioquímicas (Scriver, CR et al, 1995), revisão da literatura que abrangeu os artigos clássicos e aqueles publicados nos últimos dez anos, fornecendo assim referências atualizadas sobre as diversas doenças metabólicas hereditárias (DMH). SELEÇÃO DOS ESTUDOS: Foi realizada seleção de textos de autores consagrados pelo conhecimento e experiência na área dos EIM e descrição de casos clínicos com suas manifestações clínicas mais peculiares e marcantes. SÍNTESE DOS DADOS: Os EIM são doenças subdiagnosticadas pela falta de hábito do médico geral, neonatologista e intensivista em pensar nesta hipótese. Na revisão são descritos os mecanismos de herança, as principais características clínicas e os achados laboratoriais dos EIM, dentro de uma classificação que fornece uma visão geral sobre o assunto. São abordadas sumariamente as formas de tratamento existentes para os diversos grupos de EIM. CONCLUSÕES: Os EIM não são doenças raras como se pensava no passado e pacientes portadores de DMH fazem parte do atendimento geral nos pronto-atendimentos, nas clínicas cirúrgicas, obstétricas, pediátricas, neurológicas e psiquiátricas, aguardando diagnóstico, prognóstico e tratamento terapêutico e/ou de suporte.
Downloads
Referências
Dronamraju K. Biography - Profiles in genetics: Archibald E. Garrod (1857-1936). Am J Hum Genet 1992;51:216-9.
Scriver CR. Foreword In: Blau N, Duran M, Blaskovics ME. Physician's guide to the laboratory diagnosis of metabolic diseases. Oxford, UK: Chapman & Hall; 1996.
Waber L. Inborn errors of metabolism. Ped Ann 1990;19(2):105-17.
Wappner RS. Biochemical diagnosis of genetic diseases. Ped Ann 1993;22(5):282-97.
Saudubray JM, Charpentier C. Clinical phenotypes: Diagnosis/Algorithms. In: Scriver CR, Beaudet AL, Sly W, Valle D. The metabolic and molecular bases of inherited disease, 7th edition. McGraw-Hill; 1995.
Lindor NM, Karnes PS. Laboratory medicine and pathology: initial assessment of infants and children with suspected inborn errors of metabolism. Mayo Clin Proc 1995;70:987-8.
Wilcox WR. Inborn errors of metabolism. Online copyright (C) 1995 - World Wide Web URL: http://www.wwilcox@mailgate.csmc.edu
Walter J. How to recognize inborn errors of metabolism. The Practitioner 1995; 239:321-325.
Martins AM, Fisberg RM, Schmidt BJ. Estudio clinico de nińos brasilenos con fenilcetonuria, seguimiento a 5 ańos. Actualidad Nutricional 1995;21(2):66-70.
Seymour CA, Thomason MJ, Chalmers RA, et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess 1997;1(11):1-95.
Schmidt BJ, Martins AM, Fisberg RM, Müller R, Adell ACA, Subero EM. Fenilquetonuria: aspectos clínicos y terapéuticos. Pediatria al Dia 1987;3(5):256-7.
Camargo Neto E, Schulte J, Silva, LCS, Giugliani R. Cromatografia em camada delagada para a detecçăo neonatal de fenilcetonúria e outras aminoacidopatias. Rev Bras Anál Clín 1993;25(3):81-2.
Pinto ALR, Raymond KM, Bruck I, Antoniuk SA. Estudo de prevalęncia em recém-nascidos por defeicięncia de biotinidase. Rev Saúde Pública 1998;32(2):148-52.
Scriver CR, Beaudet AL, Sly W, Valle D. The Metabolic and Molecular Bases of Inherited Disease, 7th edition. McGraw-Hill; 1995.
Sperl W, Geiger R, Lehnert W, Rhead W. Stridor as the major presenting symptom in riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Eur J Pediatr 1997;156:800-2.
Carmant L, Decarie JC, Fon E, Shevell MI. Transient visual symptoms as the initial manifestation of childhood adrenoleukodystrophy. Pediatr Neurol 1998;19(1):62-4.
Burton BK. Inborn errors of metabolism: The clinical diagnosis in early infancy. Pediatrics 1987;79(3):359-69.
Clayton PT, Thompson E. Dysmorphic syndromes with demonstrable biochemical abnormalities. J Med Genet, 1988;25:463-72.
Seashore MR, Rinaldo P. Metabolic disease of the neonate and young infant. Semin Perinatol 1993;17(5):318-29.
Ris MD, Williams SE, Hunt MM, HK Berry, Leslie N. Early treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 1994;124(3):388-92.
Ris MD, Weber AM, Hunt MM, Berry HK, Williams SE, Leslie N. Adult psychosocial outcome in early-treated phenylketonuria. J Inherit Metab Dis 1997;20(4):499-508.
McDonnell GV, Esmonde TF, Hadden DR, Morrow, JI. A neurological evaluation of adult phenylketonuria in Northern Ireland. Eur Neurol 1998;39(1):38-43.
Cordero VC, Ayastuy IG, Andonegui GMS, et al. Increased survival rates of children with cystic fibrosis. An Esp Pediatr 1990;32(5):407-12.
Levy HL. Maternal phenylketonuria. Review with emphasis on pathogenesis. Enzyme 1987;38(1-4):312-20.
Acosta PB, Wright L. Nurse's role in preventing birth defects in offspring of women with phenylketonuria. J Obstet Gynecol Neonatal Nurs 1992;21(4):270-6.
Friedman EG, Koch R, Azen C, et al. The international collaborative study on maternal phenylketonuria: organization, study design and description of the sample. Eur J Pediatr 1996;155 (Suppl 1): S158-61.
Cipcic-Schmidt S, Trefz FK, Funders B, Seidlitz G, Ullrich K. German maternal phenylketonuria study. Eur J Pediatr 1996;155 (Suppl 1):S173-6.
Brenton DP, Lindburn M. Maternal phenylketonuria. A study from the United Kingdom. Eur J Pediatr 1996; 155 (Suppl 1):S177-80.
Koch R, Levy H, Hanley W, et al. Outcome implications of the international maternal phenylketonuria collaborative study (MPKUCS): 1994. Eur J Pediatr 1996;155 (Suppl 1): S162-4.
Michals K, Acosta PB, Austin V, et al. Nutrition and reproductive outcome in maternal phenylketonuria. Eur J Pediatr 1996;155 (Suppl 1):S165-8.
Jardim LB, Palma-Dias R, Silva LC, Ashton-Prolla P, Giugliani R. Maternal hyperphenylalaninemia as a cause of microcephaly and mental retardation. Acta Paediatr 1996;85(8):943-6.
Levy HL, Waisbren SE, Lobbregt D et al. Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr 1996;155 (Suppl 1):S20-5.
Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen storage disease. N Engl J Med 1984;310:171-3.
Talent GM, Coleman RA, Alter C, Baker L et al. Glycogen storage disease in adults. Ann Intern Med 1994;120(3):218-26.
Lee PJ, Leonard JV. The hepatic glycogen storage disease - problems beyond childhood. J Inherit Metab Dis 1995;18(4):462-72.
Sethi KD, Ray R, Roesel RA, et al. Adult-onset chorea and dementia with propionic acidemia. Neurology 1989;39:1343-5.
Lameire N, Mussche M, Baele G, Kint J, Ringoir S. Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 1978;65:416-23.
Peaston MJ. Dangers of intravenous fructose. Lancet 1973;1(7797):266.
Collins J. Metabolic disease: time for fructose solutions to go. Lancet 1993;34(8845):600.
Burmeister LA, Vaidivia T, Nuttall FQ. Adult hereditary fructose intolerance. Arch Intern Med 1991;151(4):773-6.
Couper R. Hereditary fructose intolerance in an adult. Aust N Z J Med 1996;26(2):231.
Cox TM. Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child 1993;69(4):413-5.
Rowe PC, Newman SL, Brusilow SW. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 1986;314(9):541-7.
Arn PH, Hauser ER, Thomas GH, Herman G, Hess D, Brusilow SW. Hyperammonemia in women with a mutation at the ornithine carbamyltransferase locus. N Engl J Med 1990;322(23):1652-5.
Yoshino M, Nishiyori J, Yamashita F, et al. Ornithine transcarbamylase deficiency in male adolescence and adulthood. Enzyme 1990;43(3):160-8.
Wilson BE, Hobbs WN, Newmark JJ, Farrow SJ. Rapidly fatal hyperammonemic coma in adults: urea cycle enzyme deficiency. West J Med 1994;161:166-8.
Shaw PJ, Dale G, Bates D. Familial lysinuric protein intolerance presenting as coma in two adult siblings. J Neurol Neurosurg Psychiatry 1989;52(5):648-51.
Albers SE, Brozena SJ, Glass LF, Fenske, NA. Alkaptonuria and ochronosis: case report and review. J Am Acad Dermatol 1992;27(4):609-14.
Koh KB, Low EH, Ch'ng SL, Zakiah I. A case of alkaptonuria with root canal stenosis. Singapore Med J 1994;35(1):106-7.
Reddy DR, Prasad VS. Alkaptonuria presenting as lumbar disc prolapse: case report and review of literature. Spinal Cord 1998;36(7):523-4.
Dusheiko G, Kew MC, Joffe BI, et al. Recurrent hypoglycemia associated with glutamic aciduria type II in an adult. N Engl J Med 1979;301(26):1405-9.
Pears JS, Jung RT, Hopwood, D, Waddell ID, Burchell A . Glycogen storage disease diagnosed in adults. Q J Med 1992;82(299):207-22.
Burchell A, Jung RT, Lang CC, Bennet W, Shepherd A . Diagnosis of type 1A and type 1C glycogen storage disease in adults. Lancet 1987;1(8541):1059-62.
Kurz D, Aguzzi A, Scherer TA . Decompensated cor pulmonalea: the first manifestation of adult-onset myopathy. Respiration 1998;65(4):317-9.
Cinnamon J, Slonim AE, Black KS, Gorey MT, Scuderi DM, Hyman RA. Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy. Am J Neuroradiol 1991;12(6):1099- 103.
Puig JG, de Miguel E, Mateos FA, et al. McArdle's disease and gout. Muscle Nerve 1992;15(7):822-8.
Felice KJ, Schneebaum AB, Jones HR. McArdle's disease with late-onset symptoms: case report and review of the literature. J Neurol Neurosurg Psychiatry 1992;55(5):407-8.
Chiado-Piat L, Mongini T, Doriguzzi C, Maniscalco M, Palmucci, L. Clinical spectrum of McArdle's disease: three cases with unusual expression. Eur Neurol 1993;33(3):208-11.
Thornhill MH. Masticatory muscle symptoms in a patient with McArdle's disease. Oral Surg Oral Med Pathol Oral Radiol Endod 1996;81(5):544-6.
Nicholls DP, Campbell NP, Stevenson HP, Patterson VH. Angina in McArdle's disease. Heart 1996;76(4):372-3.
Olmos JM, Zarrabeitia MT, Valero MC, Figols J, Matorras P, Riancho JA. McArdle's disease in adults: clinical and genetic study. Med Clin (Barc) 1997;109(19):753-5.
Navon R, Argov Z, Frisch A. Hexoaminidase a deficiency in adults. Am J Med Genet 1986;24:179-96.
Hurowitz GI, Silver JM, Brin MF, Williams DT, Johnson WG. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings. J Neuropsychiatry Clin Neurosci 1993;5(1):30-6.
Rosebush PI, MacQueen GM, Clarke JT, Callahan JW, Strasberg PM, Mazurek MF. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry 1995;56(8):347-53.
Hund E, Grau A, Fogel W, et al. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexoaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 1997;145(1):25-31.
MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1998;10(1):10-9.
Schlote W, Molzer B, Peiffer J et al. Adrenoleukodystrophy in an adult female: a clinical, morphological, and neurochemical study. J Neurol 19987;235(1):1-9.
De Andres C, Gimenez-Roldan S. Familial spastic paraparesis: phenotypic variant of adrenoleukodystrophy. Neurologia 1990;5(1):24-8.
Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Rev Neurosci 1991;13(4-5):254-61.
Ong BK, Lee KO, Lee T, Chong PN. An index case of adrenomyeloneuropathy in a Chinese man. Singapore Med J 1994;35(6):643-5.
Fitzgerald MA, Gross JB, Goldstein NP, Wahner HW, McCall JT. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. Mayo Clin Proc 1975,50(8):438-42.
Baban NK, Hubbs DT, Roy TM. Wilson's disease. South Med J 1997;90(5):535-8.
Bellary SV & Van Thiel DH. Wilson's disease: a diagnosis made in two individuals greater than 40 years of age. J Okla State Med Assoc 1993;86(9):441-4.
Turpin JC, Masson M, Bauman N. Clinical aspects of Nieman-Pick type C disease in adult. Dev Neurosci 1991;13(4-5):304-6.
Hulette CM, Earl NL, Anthony DC, Crain BJ. Adult onset Nieman-Pick disease type C presenting with dementia and absent organomegaly. Clin Neuropathol 1992;11(6):293-7.
Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA. Late-onset mitochondrial myopathy. Am Neurol 1995;37(1):16-23.
Kaido M, Fujimura H, Soga F, et al. Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neuropathol (Berl) 1996;92(3):312-8.
Malndrini A, Palmeri S, Fabrizi GM, et al. Juvenile Leigh syndrome with protracted course presenting chronic sensory motor neuropathy, ataxia, deafness and retinitis pigmentosa: a clinicopathological report. J Neurol Sci 1998;155(2):218-21.
Elleder M, Ledvinova J, Cieslar P, Kuhn R. Sub-clinical course of cholesterol ester storage (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process. Virchows Arch Pathol Anat Histopathol 1990;416(4):357-65.
Bauman N, Masson M, Carreau V, Lefevre M, Herschkowitz N, Turpin JC. Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Rev Neurosci 1991;13(4-5):211-15.
Flexner JM. Hemochromatosis: diagnosis and treatment. Compr Ther 1991;17(11):7-9.
Phatak PD, Cappuccio JD. Management of hereditary hemochromatosis. Blood Ver 1994;8(4):193-8.
Sveinbjornsdottir S, Blondal H, Gudmundsson G, Kjartansson O, Jonsdottir S, Gudmundsson G. Progressive dementia and leukoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopathological presentation of two cases. J Neurol Sci 1996;140(1-2):101-8.
Simon DK, Rodriguez ML, Frosh MP, Quackenbush EJ, Feske SK, Natowicz MR. A unique familial leukodystrophy with adult onset dementia and abnormal glycolipid storage: a new lysosomal disease? J Neurol Neurosurg Psychiatry 1998;65(2):251-4.
Blau N, Blaskovics ME, Duran M. Simple test in urine and blood, pp. 3-11. In: Blau, N, Duran M, Blaskovics ME. Physician' s guide to the laboratory diagnosis of metabolic diseases, 1st Edition. Oxford: Chapman & Hall Medical; 1996.
Buist N. Set of simple side-room urine tests of inborn errors of metabolism. Br Med J 1968;2:745-9.
Thomas GH, Howell RR. Selected screening tests for genetic metabolic diseases. Chicago, Year Book Medical Publishers; 1973.
Giorgio AJ, Luhby ALA. A rapid screening test for the detection of congenital methylmalonic aciduria in infancy. Am J Clin Pathol 1969;52:374-9.
Efron ML, Young D, Moser HW, MacCready RA. A simple chromatographic screening test for the detection of disorders of amino acid metabolism: a technique using whole blood or urine collected on filter paper. N Engl J Med 1964;270:1378-83.
Hoffman GF. Organic acid analysis. Part One C, pp. 31-49. In: Nenad B, Duran M, Blaskovics ME. Physician's guide to the diagnosis of metabolic diseases. Oxford: Chapman & Hall; 1996.
Shih VE. Amino acid analysis. Part 1B, pp. 13-29. In: Nenad B, Duran M, Blaskovics ME. Physician's guide to the diagnosis of metabolic diseases. Oxford: Chapman & Hall; 1996.
Stern HJ. Lactic acidosis in pediatrics: clinical and laboratory evaluation. Ann Clin Biochem 1994;31:410-9.
Ridaura-Sanz C. The pathologist's approach to the diagnosis of metabolic disease. Path Res Pract 1994;190:1109-22.
Dixon MA, Leonard JV. Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 1992;67:1387-9.
Champe PC, Harvey RA. Bioquímica Ilustrada. 2nd ed. Artes Médicas; 1996.
Harris RE, Leslie N, Krivit W. Lysosomal and peroxisomal storage disease, Part 6.11, pp. 275-285. In: Burrt RK, Deeg HJ, Lothian ST, Santos G. On call in: bone marrow transplantation. RG Landes Company; 1996.
McKinnis EJ, Sulzbacher S, Rutledge JC, Sanders J, Scott CR. Bone marrow transplantation in Hunter syndrome. J Pediatr 1996;129(1):145-8.
Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133(1):119-25.
Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The storage disease collaborative study group. Blood 1998;91(7):2601-8.
Beutler E, Demina A, Laubscher K , et al. The clinical course of treated and untreated Gaucher disease: a study of 45 patients. Blood Cells Mol Dis 1995;21(10):86-108.
Charrow J, Esplin JA, Grible TJ, et al. Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 1998;158(16):1754-60.
Damiano AM, Pastores GM, Ware JE Jr. The health-related quality of life adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study. Qual Life Res 1998;7(5):373-86.
Brooks DA, King BM, Crawley AC, Byers S, Hopwood JJ. Enzyme replacement therapy in mucopolysaccharodosis VI: Evidence for immune responses and altered efficacy of treatment in animal models. Biochim Biophys Acta 1997;1361(2):203-16.
O'Connor LH, Lawrence CE, Vogler CA, et al. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J Clin Invest 1998;101(7):1394-400.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
